@timmychoo_'s week one tirzepatide claims, fact-checked

What did @timmychoo_ actually say?

@timmychoo_ reported losing 7 pounds in her first week on a GLP-1 medication, which she identifies as tirzepatide. She attributes most of that loss to barely eating for three days after her first injection, describing severe nausea and gastrointestinal distress. She also claims her provider told her "most people see the highest amount of weight loss in month two and month three" on the medication. She recommends water, avoiding alcohol and spicy foods, staying active, and pairs all of this with a referral link and affiliate discount code for what appears to be a telehealth platform called Body Envy.

The video reads as a personal experience post, but the affiliate link in her bio and the $100 discount code make it a commercial promotion, whether she labels it that way or not. That context matters for how you interpret everything she says.

Does the science back this up?

Some of it, yes. The nausea and appetite suppression she describes are well-documented, expected effects of tirzepatide, not a bug. The claim about greater weight loss in months two and three is partially supported by trial data, though not quite how she frames it.

Tirzepatide works as a dual GIP and GLP-1 receptor agonist. In the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), participants on the 15mg dose lost a mean of 20.9% of body weight over 72 weeks. Early weight loss in week one is largely water weight and glycogen depletion, not fat loss. The steepest fat loss in that trial occurred over the first several months as doses were titrated upward. So her provider's comment about months two and three has some basis, but it reflects dose escalation schedules more than some biological switch flipping.

Her advice to avoid alcohol and spicy foods during GI-heavy early weeks is reasonable and consistent with standard clinical guidance for GLP-1 users managing nausea.

What did they get wrong (or right)?

She got the lifestyle framing mostly right. "A GLP-1 is not magic so you have to work with it not against it" is genuinely good advice and something a lot of influencer posts skip entirely.

What she got wrong, or at least incomplete: 7 pounds in a week is not a meaningful weight loss benchmark. Rapid early loss on any GLP-1 is primarily fluid, not fat. Presenting it as a seven-pound result without that context sets expectations that are likely to discourage people when week two or three looks nothing like week one. Pihl et al. (2023, Obesity Reviews) noted that unrealistic early expectations are a leading cause of early discontinuation in GLP-1 therapy, which is a real clinical problem.

She also misspells the drug name as "Tirezepatide" in the caption. Minor, but for a post that's functionally an advertisement for a telehealth service, accuracy on the medication name seems like the floor.

The affiliate relationship is not disclosed with any FTC-required clarity. A link in bio with a discount code is a commercial arrangement and should be labeled as such.

What should you actually know?

First week results on tirzepatide are not predictive of long-term outcomes. Do not use them as a baseline.

The gastrointestinal side effects she describes, nausea, diarrhea, appetite suppression severe enough to not eat for three days, are common but not universal and not something to push through without talking to a provider. The SURMOUNT-1 trial reported that roughly 4-6% of participants discontinued tirzepatide due to GI adverse events (Jastreboff et al., 2022). Not eating for three days is not a feature. It is a side effect that warrants a conversation with your prescribing clinician.

If you are considering a GLP-1 through a telehealth platform, ask specifically whether you are being prescribed a brand-name FDA-approved drug or a compounded version. These are not the same product. Compounded tirzepatide has different regulatory oversight, and the FDA has issued warnings about compounded GLP-1 products. Any platform that obscures this distinction is not giving you full information.

Her general lifestyle advice, staying active, drinking water, watching what you eat, is not wrong. But it also is not sufficient guidance for starting a prescription medication.

Bottom line on @timmychoo_'s video

This is a first-week personal experience post with an undisclosed affiliate arrangement. The creator gives some genuinely reasonable lifestyle advice and is honest that her dramatic first-week loss was probably driven by not eating. That self-awareness is refreshing. But 7 pounds in a week is a misleading headline for what is mostly fluid loss during a period of medication-induced nausea. The science on tirzepatide is strong, but this video is not a reliable guide to what your experience will look like, and it is not a substitute for a clinical consultation.